Announcements Trials
Browse Landscape

Status

Completed 359Recruiting 130Terminated 125Unknown 101Active not recruiting 46Withdrawn 38Not yet recruiting 25No longer available 5Approved for marketing 4Enrolling by invitation 3Suspended 2Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 3Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Myeloid, Acute 3Sarcoma 2Multiple Myeloma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Thalassemia 1Stomach Neoplasms 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Metabolic Diseases 1Mastocytosis, Systemic 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell 1Leukemia, Plasma Cell 1Leukemia, Mast-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hematologic Neoplasms 1Glioblastoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Recurrence × Lymphoid × Clear all
NCT05619367 2025-12-23

A Compassionate Use (CU) Program of Odronextamab

Regeneron Pharmaceuticals

Available
Lymphoid

Lymphoma, Follicular, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡